Search tool

Document library

Implementation of the Icelandic Prevention Model

In this paper we highlight the Icelandic Prevention Model’s strengths and raise some critical concerns that should be considered and dealt with before implementing, adapting and evaluating the model in other contexts.

Cover page of risk assessment guidelines

Manuals and guidelines

EMCDDA operating guidelines for the risk assessment of new psychoactive substances

The purpose of these guidelines is to ensure compliance with the scope and requirements of Regulation (EC) No 1920/2006 (as amended) and Council Framework Decision 2004/757/JHA (as amended) in respect to the...

map highlighting EU4MD partner countries

EMCDDA releases study findings on the impact of COVID-19 on drug markets, use and services in the southern ENP region

The emergence of new drug trafficking routes, the reduced availability of drug-related health services and the adaptation of drug treatment protocols during the COVID-19 pandemic are among the findings highlighted today in...

Cover page of the trendspotter briefing

Ad hoc publication

Impact of COVID-19 on drug markets, drug use, drug-related harms and responses in south European Neighbourhood Policy countries

Since the beginning of 2020, the world has been experiencing an unprecedented public health emergency caused by the coronavirus disease (COVID-19) pandemic, which has led to progressive introduction of social distancing and...

Publication cover: Low-THC cannabis products in Europe / December 2020

Ad hoc publication

Low-THC cannabis products in Europe

An increase in the open sale of cannabis products in Europe has raised questions around the possible legal and commercial status of these products. The products are marketed for their low THC...

25 years of monitoring: highlights of the year

Rounding off our 25 years of monitoring celebrations.

EMCDDA Voices: Alexis Goosdeel

EMCDDA Voices: Alexis Goosdeel

Rounding off our 25 years of monitoring celebrations, our Director Alexis Goosdeel comments on the EMCDDA past, present and future and declares ‘We are ready for the next 25 years!’ #emcdda25

Launch of report: Low-THC cannabis products in Europe

The report Low-THC cannabis products in Europe is available at the EMCDDA's publication database. See also the news section.

New report explores open sale of low-THC cannabis products and regulatory responses in Europe

An increase in the open sale of cannabis products in Europe has raised questions around the possible legal and commercial status of these products. In a new report released today, Low-THC cannabis...

Document library

Council of the EU (2020) EU Drugs Strategy 2021-25

This document presents the Council of the European Union's Drugs Strategy 2021-25.